Skip to main content
رجوع
Watch Compare

Voyager Therapeutics, Inc.

جودة البيانات: 100%
VYGR
Nasdaq Manufacturing Chemicals
KWD 3.97
▲ KWD 0.05 (1.28%)
القيمة السوقية: 236.61 M
السعر
KWD 3.97
القيمة السوقية
236.61 M
نطاق اليوم
KWD 3.86 — KWD 4.01
نطاق 52 أسبوعًا
KWD 2.65 — KWD 5.55
حجم التداول
367,638
فتح KWD 3.89
متوسط 50 يوم / 200 يوم
KWD 3.93
0.97% above
متوسط 50 يوم / 200 يوم
KWD 3.95
0.43% above

Quick Summary

النقاط الرئيسية

Revenue grew 1.92% annually over 5 years — modest growth
Negative free cash flow of -135.06 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 51.45%
Capital efficient — spends only 6.43% of revenue on capex

النمو

Revenue Growth (5Y)
1.92%
أقل من متوسط القطاع (9.35%)
Revenue (1Y)-49.53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-51.63%
أقل من متوسط القطاع (-51.02%)
ROIC-39.09%
Net Margin-296.53%
Op. Margin-326.56%

الأمان

Debt / Equity
N/A
Current Ratio6.19
Interest CoverageN/A

التقييم

PE (TTM)
-1.98
أقل من متوسط القطاع (-1.98)
P/B Ratio1.08
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -2.0 -2.0
P/B 1.1 5.1
ROE % -51.6 -51.0
Net Margin % -296.5 -150.2
Rev Growth 5Y % 1.9 9.3
D/E — 0.3

ETFs Holding This Stock

EES logo EES WisdomTree U.S. SmallCap Fund
0.04% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.02% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -49.53% Revenue Growth (3Y) -59.81%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 1.92% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40.37 M Net Income (TTM) -119.72 M
ROE -51.63% ROA -39.23%
Gross Margin N/A Operating Margin -326.56%
Net Margin -296.53% Free Cash Flow (TTM) -135.06 M
ROIC -39.09% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.19
Interest Coverage N/A Asset Turnover 0.13
Working Capital 184.09 M Tangible Book Value 219.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.98 Forward P/E N/A
P/B Ratio 1.08 P/S Ratio 5.86
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -57.08%
Market Cap 236.61 M Enterprise Value 191.48 M
Per Share
EPS (Diluted TTM) -2.04 Revenue / Share 0.68
FCF / Share -2.27 OCF / Share -2.22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6.43% FCF Conversion 112.81%
SBC-Adj. FCF -149.76 M Growth Momentum -51.45

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 40.37 M 80.00 M 250.01 M 40.91 M 37.42 M
Net Income -119.72 M -65.00 M 132.33 M -46.41 M -71.20 M
EPS (Diluted) -2.04 -1.13 2.97 -1.21 -1.89
Gross Profit — — — — —
Operating Income -131.84 M -83.29 M 122.01 M -50.84 M -73.62 M
EBITDA — — — — —
R&D Expenses 134.67 M 127.37 M 92.17 M 60.76 M 73.79 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 144,000.0 665,000.0 1.41 M 16,000.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 252.28 M 393.05 M 351.28 M 159.36 M 193.86 M
Total Liabilities 56.20 M 93.29 M 114.96 M 100.34 M 98.80 M
Shareholders' Equity 196.08 M 299.76 M 236.32 M 59.02 M 95.06 M
Total Debt — — — — —
Cash & Equivalents 65.30 M 71.37 M 68.80 M 98.96 M 117.43 M
Current Assets 202.69 M 276.81 M 319.68 M 124.50 M 136.70 M
Current Liabilities 26.54 M 49.79 M 64.51 M 72.59 M 50.98 M